Persistent Asset Partners »

Immunome shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $183k 8.5k 21.48

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Immunome

T. Rowe Price Investment Management
FMR
BlackRock
Point72 Asset Management
Vanguard Group
Redmile Group
Enavate Sciences GP
PRIMECAP Management Company
Leucadia National Corporation
State Street Corporation
EcoR1 Capital
Geode Capital Management
Toronto-Dominion Bank
Readystate Asset Management
Sofinnova Ventures

View all funds holding Immunome